{{Rsnum
|rsid=183460
|Gene=NPAT
|Chromosome=11
|position=108219983
|Orientation=plus
|GMAF=0.4839
|Gene_s=NPAT
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 19.5 | 54.0 | 26.5
| HCB | 30.7 | 47.4 | 21.9
| JPT | 31.0 | 46.0 | 23.0
| YRI | 38.8 | 51.0 | 10.2
| ASW | 33.3 | 42.1 | 24.6
| CHB | 30.7 | 47.4 | 21.9
| CHD | 29.4 | 49.5 | 21.1
| GIH | 9.9 | 39.6 | 50.5
| LWK | 57.3 | 36.4 | 6.4
| MEX | 22.4 | 41.4 | 36.2
| MKK | 52.6 | 37.2 | 10.3
| TSI | 12.7 | 33.3 | 53.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21050672
|Title=Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}